SNOA - Sonoma Pharmaceuticals Inc

Momentum: Bearish

Recent News

Despite Fast-paced Momentum, Sonoma Pharmaceuticals ( SNOA ) Is Still a Bargain Stock

Zacks Commentary • 3 weeks, 6 days ago • score: 0.47

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Sonoma Pharmaceuticals (SNOA) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Bullish

Sonoma Pharmaceuticals ( SNOA ) Is Attractively Priced Despite Fast-paced Momentum

Zacks Commentary • 2 months ago • score: 0.43

Bullish

Fast-paced Momentum Stock Sonoma Pharmaceuticals ( SNOA ) Is Still Trading at a Bargain

Zacks Commentary • 5 months, 2 weeks ago • score: 0.43

Sonoma Pharmaceuticals (SNOA) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company is headquartered in Woodstock, Georgia.

52W High

$6.92

52W Low

$1.75

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.40

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-0.17

EV/Revenue (<3 favorable)

0.33

P/S (TTM) (<3 favorable)

0.52

P/B (<3 favorable)

1.92

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

1.23%

Institutions (25–75% balanced)

6.31%

Shares Outstanding

1,643,300

Float

1,622,300

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

14,912,000

Gross Profit (TTM)

5,623,000

EPS (TTM)

-2.21

Profit Margin (>10% good)

-0.24%

Operating Margin (TTM) (higher better)

-0.27%

ROE (TTM) (>15% strong)

-0.79%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

0.18

Momentum

Bearish momentum

Value

0.1755

0.2031

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025